Companies

Celgene

NASDAQ: CELG
$108.24
▲ $0.00 (+0.00%) today
Markets closed · 3:58am ET

CELG Coverage

Page 7
10:35am ET
Health and Healthcare

Why Celgene Shares Took a Step Back

Celgene saw its shares take a step back on Friday after the firm announced results from a late-stage clinical study of patients with follicular lymphoma.

Chris Lange
10:40am ET
Health and Healthcare

Short Sellers Chase Biotechs Higher

The October 13 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.

Chris Lange